Fresenius Kabi announced the launch of Glucagon Emergency Kit for the treatment of severe hypoglycemic episodes in adult and pediatric patients with diabetes.
Glucagon for Injection is an antihypoglycemic agent that is designed for convenience and ease of use. The kit includes 1 vial of lyophilized powder of Glucagon for Injection (1mg) and 1 prefilled disposable syringe with sterile water (1mL) for reconstitution.
After mixing the dry powder with the syringe of sterile water, the product should be used immediately; any unused Glucagon should be thrown away. The prefilled syringe that comes with the kit should only be used with Glucagon and is not meant for use with other medications.
Selection of the appropriate dose of Glucagon is based on body weight and age. Glucagon for Injection can be administered intramuscularly or subcutaneously into the upper arms, thighs, or buttocks.
“For people with diabetes, a severe hypoglycemic episode can occur anywhere and at any time,” said John Ducker, president and CEO of Fresenius Kabi USA. “Our new Glucagon Emergency Kit allows clinicians flexibility and choice for treating patients experiencing severe hypoglycemia.”
To help educate patients, clinicians can order a complimentary training kit that does not include the active ingredient. The Company is also offering a co-pay assistance program for eligible patients.
For more information visit glucagonemergencykit.com.
This article originally appeared on MPR